CYTOKINES MODULATE THE SENSITIVITY OF HUMAN FIBROBLASTS TO STIMULATION WITH INSULIN-LIKE GROWTH FACTOR-I (IGF-I) BY ALTERING ENDOGENOUS IGF-BINDING PROTEIN-PRODUCTION

被引:87
作者
YATEMAN, ME [1 ]
CLAFFEY, DC [1 ]
HUGHES, SCC [1 ]
FROST, VJ [1 ]
WASS, JAH [1 ]
HOLLY, JMP [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,DEPT ENDOCRINOL,W SMITHFIELD,LONDON EC1A 7BE,ENGLAND
关键词
D O I
10.1677/joe.0.1370151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human dermal fibroblasts produce a number of insulin-like growth factor-binding proteins (IGFBPs) including the main circulating form, IGFBP-3. It has been suggested that the regulation of IGFBP secretion may play a major role in modulating insulin-like growth factor (IGF) bioactivity. We have quantified the effects of two cytokines, transforming growth factor-beta1 (TGF-beta1) and tumour necrosis factor-alpha (TNF-alpha) which have opposing actions on fibroblast IGFBP-3 production, and examined their subsequent role in IGF-I mitogenesis. TGF-beta1 caused a dose-dependent increase in IGFBP-3 in serum-free fibroblast-conditioned media. TGF-beta1 (I mug/1) resulted in immunoreactive IGFBP-3 levels reaching 286.5 +/-22.4% of control after 20 h, the increase being confirmed by Western ligand blot. TNF-alpha caused a dose-dependent decrease in fibroblast IGFBP-3 secretion, 1 mug TNF-alpha/I reducing IGFBP-3 levels to 32.1 +/-11.% of control. This effect was not due to cytotoxicity and was not cell-density-dependent. Fibroblast proliferation was examined using a 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MT-colorimetric cytochemical bioassay. The addition of IGF-I resulted in dose-dependent growth stimulation after 48 h, the effective range being 20-100 mug/l. The IGF-I analogue Long-R3-IGF-I which has little affinity for the IGFBPs was approximately 20-fold more potent in this assay, and was unaffected by exogenous IGFBP-3. While the addition of 1 mug TGF-beta1/1 to increasing doses of IGF-I resulted in a fourfold decrease in mitogenic sensitivity to the IGF-I, no such effect was seen with Long-R3-IGF-I. Conversely, 1 mug TNF-alpha/1 increased fibroblast IGF-I sensitivity five-fold, an effect not observed with the IGF-I analogue. Such data suggest that endogenous IGFBP-3 inhibits IGF-I bioactivity and that the regulation of IGF mitogenesis by TGF-beta1 and TNF-alpha can occur via local IGFBP modulation. This may represent a mechanism by which complex growth signals are co-ordinated in vivo.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 27 条
[1]   BINDING-PROPERTIES AND BIOLOGICAL POTENCIES OF INSULIN-LIKE GROWTH-FACTORS IN L6 MYOBLASTS [J].
BALLARD, FJ ;
READ, LC ;
FRANCIS, GL ;
BAGLEY, CJ ;
WALLACE, JC .
BIOCHEMICAL JOURNAL, 1986, 233 (01) :223-230
[3]  
CLEMMONS DR, 1990, J BIOL CHEM, V265, P12210
[4]   GLYCOSYLATION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 (IGFBP-3) IS NOT REQUIRED FOR POTENTIATION OF IGF-I ACTION - EVIDENCE FOR PROCESSING OF CELL-BOUND IGFBP-3 [J].
CONOVER, CA .
ENDOCRINOLOGY, 1991, 129 (06) :3259-3268
[5]   MITOGENS REGULATE THE PRODUCTION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN BY SWISS 3T3 CELLS [J].
CORPS, AN ;
BROWN, KD .
ENDOCRINOLOGY, 1991, 128 (02) :1057-1064
[6]   THE INDUCTION OF A SPECIFIC PROTEASE FOR INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IN THE CIRCULATION DURING SEVERE ILLNESS [J].
DAVIES, SC ;
WASS, JAH ;
ROSS, RJM ;
COTTERILL, AM ;
BUCHANAN, CR ;
COULSON, VJ ;
HOLLY, JMP .
JOURNAL OF ENDOCRINOLOGY, 1991, 130 (03) :469-&
[8]  
Drop S.L.S., 1991, MODERN CONCEPTS INSU, P311
[9]   ESTA - A BIOASSAY SYSTEM FOR THE DETERMINATION OF THE POTENCIES OF HORMONES AND ANTIBODIES WHICH MIMIC THEIR ACTION [J].
EALEY, PA ;
YATEMAN, ME ;
HOLT, SJ ;
MARSHALL, NJ .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1988, 1 (02) :R1-R4
[10]  
FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443